At the Panacea Biotec office, conversations around DengiAll are cloaked with an air of eagerness. With the human trials enrollment ending with over 10,000 participants, the company is waiting for approval.
With govt's local clinical trials waiver for certain drugs and vaccines, Japanese firm Takeda may soon launch QDenga, which will be a boost for India’s fight against dengue.
The VFX effects are what you’d expect from a run-of-the-mill video game or a mediocre fantasy show. But a film that supposedly cost thousands of crores? The audience deserves more.
Hormuz crisis is only the latest in a line of geopolitical flashpoints that shaped India’s energy strategy over the years, starting from OPEC oil embargo that followed the Yom Kippur war.
Three-day conflict between India and Pakistan underscored the growing importance of information warfare as a critical domain alongside conventional military operations.
It’s easy to understand why the government can’t speak the hard truth. When this war ends, as all wars do, India’s interests will lie with both the winner and the loser.
COMMENTS